Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,481 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Completed

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera

NCT01243073

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • MDACC - Orlando Orlando, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University - Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States
View Trial Details
Completed

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

NCT02085993

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Research Site Innsbruck, Austria
  • Research Site Leoben, Austria
  • Research Site Bruges, Belgium
  • Research Site Ghent, Belgium
View all 22 locations
View Trial Details
Completed

Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients

NCT02002702

Conditions
Acute Heart Failure, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +14 more
Locations
  • Novartis Investigative Site Seto, Aichi-ken, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Iizuka, Fukuoka, Japan
  • Novartis Investigative Site Hiroshima, Japan
View all 15 locations
View Trial Details
Completed

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

NCT00586651

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • NY Presbyterian-Cornell New York, United States
  • Mount Sinai School of Medicine New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions